The Supreme Court has unanimously rejected a lawsuit challenging the Food and Drug Administration's approach to regulating the abortion pill mifepristone. This ruling allows the pills to continue to be mailed to patients without requiring an in-person doctor's visit.
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
Supreme Court Rejects Lawsuit Challenging FDA's Abortion Pill Regulation
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks